Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.48
-0.1524-0.64%
Volume:2K
Turnover:40.34K
Market Cap:4.70M
PE:- -
High:23.71
Open:23.71
Low:23.48
Close:23.63
52wk High:24.29
52wk Low:15.67
Shares:200.00K
Float Shares:200.00K
Volume Ratio:2.35
T/O Rate:0.85%
Dividend:0.77
Dividend Rate:3.28%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Cboe data shows mixed options sentiment in Moderna with shares down 1.81%

TIPRANKS
·
Yesterday

Moderna Shares Reverse Course, Last Down 1.3%

THOMSON REUTERS
·
Yesterday

Nvidia, Tesla, Seagate, on Semi, Strategy, HPE, and More Stocks That Explain Today's Market

Dow Jones
·
Yesterday

Update: US Equity Futures Higher Pre-Bell as Traders Monitor Oil Prices, Assess September Jobs Report

MT Newswires Live
·
Yesterday

U.S. Stocks on the MOVE-Moderna, Nike, Synaptics

Reuters
·
Yesterday

Correction: Top Midday Decliners

MT Newswires Live
·
Yesterday

US Stocks-Wall St Futures Rise Ahead of Jobs Report as Bond Market Steadies, Oil Slips

Reuters
·
Yesterday

On Semi, Synaptics, Nike, Strategy, Moderna, and More Stocks That Explain Today's Market

Dow Jones
·
Yesterday

Warner Bros. Stock is About to Leave the Nasdaq. Here's What's Replacing It.

Dow Jones
·
Yesterday

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Yesterday

Moderna Shares Rise on Planned NASDAQ 100 Entry

Reuters
·
Yesterday

Moderna Shares Rise 2.8% Premarket After Co to Join NASDAQ-100 Index, Effective October 9

THOMSON REUTERS
·
Yesterday

Novartis Strikes up to $7.8 Billion mRNA Deal with China's Abogen

Reuters
·
Yesterday

Why Did Moderna Stock Gain (MRNA) in After-Hours Trading on Thursday?

TIPRANKS
·
Yesterday

Moderna to Join Nasdaq 100, Replacing Warner Bros Discovery

Reuters
·
Yesterday

Rpt-NASDAQ - Moderna to Join NASDAQ-100 Index Replacing Warner Bros. Discovery on October 9, 2026

THOMSON REUTERS
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Trump Medicare Drug Pricing Model May Apply to Only Four Companies After Exemptions

Reuters
·
Yesterday

Eli Lilly's Obesity Data Support Broader Portfolio Beyond Tirzepatide, UBS Says

MT Newswires Live
·
Yesterday

Eli Lilly (LLY) Ends Cancer Development Deal with Foghorn Therapeutics

TIPRANKS
·
Oct 01